Serum CDA activity has been evaluated as a biomarker of inflammatory activity in different inflammatory diseases, including rheumatoid arthritis and gout.14,15 These findings support further studies performing parallel measurements of biomarkers of inflammation, such as C-reactive protein (CRP). The gene discussed is CDA; the disease is gout.